- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Children (1-11 years)
- Adolescents (12-17 years)
- Hospital
- Non-hospital health centre
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Adenovirus
- Rhinovirus
- Parainfluenza Virus
- Metapneumovirus
Population: Children (1-11 years)
- General population
- Infants (<1 year)
- Children (1-11 years)
- Hospital
- Primary care
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Human metapneumovirus
- General population
- Infants (<1 year)
- Children (1-11 years)
- Primary care
- Respiratory syncytial virus
- Adults (18-64 years)
- General population
- Children (1-11 years)
- Adolescents (12-17 years)
- People at high risk of STIs
- Men who have sex with men
- Primary care
- Monkeypox virus
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Children (1-11 years)
- Adolescents (12-17 years)
- Community
- Monkeypox virus
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Children (1-11 years)
- Adolescents (12-17 years)
- Outpatient clinic
- Arbovirus
- Dengue virus
- Vector-borne disease
- Blood sample
- Pharmacological intervention
- Vaccination
- Qdenga
- Adults (18-64 years)
- General population
- Infants (<1 year)
- Children (1-11 years)
- Pregnant women
- Community
- Arbovirus
- Vector-borne disease
- Zika virus
- Blood sample
- Urine sample
- Hair
- Saliva
- Semen
- Vaginal fluids
- Adults (18-64 years)
- Elderly (≥65 years)
- Children (1-11 years)
- Adolescents (12-17 years)
- Hospital
- Neisseria gonorrhoeae
- Adults (18-64 years)
- Elderly (≥65 years)
- Infants (<1 year)
- Children (1-11 years)
- Adolescents (12-17 years)
- Hospital
- Outpatient clinic
- Emergency department
- Arbovirus
- Chikungunya virus
- Vector-borne
- Dengue virus
- Zika virus
- West Nile virus
- Japanese encephalitis virus
- Adults (18-64 years)
- General population
- Children (1-11 years)
- Adolescents (12-17 years)
- Community
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Adults (18-64 years)
- Elderly (≥65 years)
- Children (1-11 years)
- Adolescents (12-17 years)
- Community
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- General population
- Infants (<1 year)
- Children (1-11 years)
- Adolescents (12-17 years)
- Hospital
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome